SHILPA MEDICARE
Quarterly Results Analysis [Sep2025]
SHILPA MEDICARE Quarterly Results
| Consolidated | Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹370 Cr | ₹321 Cr | ₹331 Cr | ₹319 Cr | ₹344 Cr | ₹293 Cr | ₹292 Cr | ₹287 Cr |
| Expenses | ₹262 Cr | ₹230 Cr | ₹254 Cr | ₹239 Cr | ₹258 Cr | ₹219 Cr | ₹222 Cr | ₹221 Cr |
| Operating Income | ₹108 Cr | ₹92 Cr | ₹77 Cr | ₹81 Cr | ₹86 Cr | ₹74 Cr | ₹70 Cr | ₹66 Cr |
| Other Income | ₹2 Cr | ₹6 Cr | ₹8 Cr | ₹1 Cr | ₹5 Cr | ₹10 Cr | ₹2 Cr | ₹2 Cr |
| Interest | ₹16 Cr | ₹19 Cr | ₹14 Cr | ₹12 Cr | ₹26 Cr | ₹24 Cr | ₹24 Cr | ₹26 Cr |
| Depreciation | ₹30 Cr | ₹29 Cr | ₹29 Cr | ₹29 Cr | ₹28 Cr | ₹27 Cr | ₹27 Cr | ₹27 Cr |
| Profit Before Tax | ₹65 Cr | ₹50 Cr | ₹13 Cr | ₹41 Cr | ₹37 Cr | ₹32 Cr | ₹28 Cr | ₹15 Cr |
| Profit After Tax | ₹44 Cr | ₹48 Cr | ₹12 Cr | ₹31 Cr | ₹18 Cr | ₹18 Cr | ₹25 Cr | ₹6 Cr |
| EPS | ₹4.51 | ₹2.40 | ₹0.74 | ₹1.63 | ₹1.83 | ₹0.72 | ₹1.41 | ₹0.26 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SHILPA MEDICARE | 6.5% | 7.1% | -5.2% |
| SUN PHARMACEUTICAL INDUSTRIES | 2.5% | 4% | -3.3% |
| DIVIS LABORATORIES | -1% | 0.5% | 9.4% |
| CIPLA | 1.4% | -2.4% | -3.4% |
| TORRENT PHARMACEUTICALS | 6.9% | 8.7% | 21% |
| DR REDDYS LABORATORIES | 2.4% | -2.2% | -4.5% |
| MANKIND PHARMA | -0.3% | -7.6% | -16.6% |
| ZYDUS LIFESCIENCES | 0% | -5% | -2.2% |
| LUPIN | 4.1% | 4.2% | -3.5% |
SHILPA MEDICARE Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 15.09 % |
| Y-o-Y | 7.61 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Sep2025 | ₹370 Cr | 15.09 | |
| Jun2025 | ₹321 Cr | -2.83 | |
| Mar2025 | ₹331 Cr | 3.60 | |
| Dec2024 | ₹319 Cr | -7.12 | |
| Sep2024 | ₹344 Cr | 17.53 | |
| Jun2024 | ₹293 Cr | 0.28 | |
| Mar2024 | ₹292 Cr | 1.72 | |
| Dec2023 | ₹287 Cr | - | |
SHILPA MEDICARE Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 18.17 % |
| Y-o-Y | 25.90 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Sep2025 | ₹108 Cr | 18.17 | |
| Jun2025 | ₹92 Cr | 19.36 | |
| Mar2025 | ₹77 Cr | -4.86 | |
| Dec2024 | ₹81 Cr | -6.18 | |
| Sep2024 | ₹86 Cr | 16.98 | |
| Jun2024 | ₹74 Cr | 4.94 | |
| Mar2024 | ₹70 Cr | 5.78 | |
| Dec2023 | ₹66 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 2.67 % |
| Y-o-Y | 16.99 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Sep2025 | 29.27% | 2.67 | |
| Jun2025 | 28.51% | 22.83 | |
| Mar2025 | 23.21% | -8.15 | |
| Dec2024 | 25.27% | 1.00 | |
| Sep2024 | 25.02% | -0.44 | |
| Jun2024 | 25.13% | 4.62 | |
| Mar2024 | 24.02% | 3.98 | |
| Dec2023 | 23.1% | - | |
SHILPA MEDICARE Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -7.22 % |
| Y-o-Y | 140.99 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Sep2025 | ₹44 Cr | -7.22 | |
| Jun2025 | ₹48 Cr | 290.06 | |
| Mar2025 | ₹12 Cr | -61.17 | |
| Dec2024 | ₹31 Cr | 71.51 | |
| Sep2024 | ₹18 Cr | 4.28 | |
| Jun2024 | ₹18 Cr | -28.66 | |
| Mar2024 | ₹25 Cr | 327.24 | |
| Dec2023 | ₹6 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -19.38 % |
| Y-o-Y | 124.02 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Sep2025 | 11.94 % | -19.38 | |
| Jun2025 | 14.81 % | 301.36 | |
| Mar2025 | 3.69 % | -62.54 | |
| Dec2024 | 9.85 % | 84.80 | |
| Sep2024 | 5.33 % | -11.31 | |
| Jun2024 | 6.01 % | -28.88 | |
| Mar2024 | 8.45 % | 320.40 | |
| Dec2023 | 2.01 % | - | |
SHILPA MEDICARE Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 87.92 % |
| Y-o-Y | 146.45 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Sep2025 | ₹4.51 | 87.92 | |
| Jun2025 | ₹2.4 | 224.32 | |
| Mar2025 | ₹0.74 | -54.60 | |
| Dec2024 | ₹1.63 | -10.93 | |
| Sep2024 | ₹1.83 | 154.17 | |
| Jun2024 | ₹0.72 | -48.94 | |
| Mar2024 | ₹1.41 | 442.31 | |
| Dec2023 | ₹0.26 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD